Systemic sclerosis following oral contraception

Clinical Rheumatology

Volumn 24, Issue 3, 2005, Pages 316-317

  Beretta, Lorenzo ^a   Caronni, Monica ^a   Scorza, Raffaella ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DROSPIRENONE PLUS ETHINYLESTRADIOL; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; THROMBIN;

ADULT; ARTICLE; CASE REPORT; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FEMALE; HUMAN; LABORATORY TEST; MENSTRUATION DISORDER; ORAL CONTRACEPTION; PRIORITY JOURNAL; RAYNAUD PHENOMENON; RISK ASSESSMENT; SYSTEMIC SCLEROSIS; THROMBOSIS;

ADULT; ALDOSTERONE ANTAGONISTS; ANDROSTENES; ANTIBODIES, ANTINUCLEAR; BIOLOGICAL MARKERS; CENTROMERE; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HOMOCYSTEINE; HUMANS; MENSTRUATION DISTURBANCES; MICROSCOPIC ANGIOSCOPY; PROGESTERONE CONGENERS; SCLERODERMA, SYSTEMIC;

EID: 20944440610     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-004-0963-y     Document Type: Article

References (10)

1. Kahaleh MB, LeRoy EC (1999) Autoimmunity and vascular involvement in systemic sclerosis (SSc). Autoimmunity 31:195 1:STN:280:DC%2BD3c3gtF2nsQ%3D%3D
2. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581-590 7378088
3. Wigley FM (2001) When is scleroderma really scleroderma (review)? J Rheumatol 28:1471-1473 1:STN:280:DC%2BD38%2Fit1Oktg%3D%3D
4. Suzuki T, Nakamura Y, Moriya T, Sasano H (2003) Effect of steroid hormones on vascular functions. Microsc Res Tech 60:76-84 10.1002/ jemt.10246
5. Kuller LH (2003) Hormone replacement therapy and risk of cardiovascular disease. Aterioscler Thromb Vasc Biol 23:11-26 10.1161/ 01.ATV.0000046033.32478.6D
6. Ames PR, Lupoli S, Alves J, Atsumi T, Edwards C, Iannaccone L, Khamashta MA, Hughes GR, Brancaccio V (1997) The coagulation/fibrinolysis balance in systemic sclerosis: Evidence for a haematological stress syndrome. Br J Rheumatol 36:1045-1050 10.1093/rheumatology/36.10.1045
7. Coughlin SR (2000) Thrombin signalling and protease-activated receptors. Nature 407:258-264 10.1038/35025229
8. Hekert O, Kuhl H, Sandow J, Busse R, Schini-Kert VB (2001) Sex steroids in hormonal treatment increase vascular procoagulant activity by inducing thrombin receptor (PAR-1) expression. Role of the glucocorticoid receptor. Circulation 104:2826-2831 11733402
9. Pollow K, Juchem M, Elger W, Jacobi N, Hoffman G, Mobus V (1992) Dihydrospirornone (ZK30595): A novel synthetic progestagen - characterization of binding to different receptor proteins. Contraception 46:561-574 10.1016/0010-7824(92)90121-9
10. Van Grootheest K, Vrieling T (2003) Thromboembolism associated with the new contraceptive Yasmin. BMJ 326:257 10.1136/bmj.326.7383.257